Asplenia secondary prevention

Revision as of 14:39, 20 July 2021 by Kalpana (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Asplenia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Asplenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Asplenia secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Asplenia secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Asplenia secondary prevention

CDC on Asplenia secondary prevention

Asplenia secondary prevention in the news

Blogs on Asplenia secondary prevention

Directions to Hospitals Treating Asplenia

Risk calculators and risk factors for Asplenia secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kalpana Giri, MBBS[2]

Overview

Effective measures for the secondary prevention of asplenia include: Patient should carry an alert card or bracelet and an up-to-date vaccination record. The risk of infection can be significantly reduced by using systematic, long-term approaches. Patient and family education program that addresses the risk of infection in these at-risk patients.

Secondary Prevention

Effective measures for the secondary prevention of asplenia include:

References

  1. O'Neill NE, Baker J, Ward R, Johnson C, Taggart L, Sholzberg M (2020). "The development of a quality improvement project to improve infection prevention and management in patients with asplenia or hyposplenia". BMJ Open Qual. 9 (3). doi:10.1136/bmjoq-2019-000770. PMC 7410002 Check |pmc= value (help). PMID 32759171 Check |pmid= value (help).
  2. Lee GM (2020). "Preventing infections in children and adults with asplenia". Hematology Am Soc Hematol Educ Program. 2020 (1): 328–335. doi:10.1182/hematology.2020000117. PMC 7727556 Check |pmc= value (help). PMID 33275684 Check |pmid= value (help).

Template:WH Template:WS